AMETEK (AME) Could Be 14% Undervalued As Order And Margin Hopes Build
AMETEK (AME) stock continues to reflect investor attention after recent trading, with the shares last closing at US$239.55. The company’s multi segment industrial profile and steady financial metrics keep it in focus for long term holders.
See our latest analysis for AMETEK.
Recent trading has been choppy for AMETEK, with the 7 day share price return down 5.75% and the 30 day share price return down 1%. However, the year to date share price return of 14.54% and 1 year total shareholder return of 29.90% point to momentum that has been building over a longer horizon.
If you are comparing AMETEK with other industrial and automation related opportunities, it can help to widen the lens and review 37 robotics and automation stocks
After a strong longer term run and a recent pullback, AMETEK now sits at a level where opinions split between further upside ahead and most gains already priced in. How does the current valuation compare with its record so far?
Most Popular Narrative: 13.7% Undervalued
At a last close of $239.55 versus a narrative fair value of $277.50, the current view on AMETEK builds in a meaningful valuation gap that hinges on how future orders, margins, and acquisitions play out from here.
EMG and Automation segments are inflecting upwards, with destocking now complete and record orders translating to accelerating organic growth and strong core margin expansion, this shift is poised to further enhance operating leverage and group EBITDA growth in coming quarters.
Want to see the engine behind that fair value for AMETEK? The narrative leans on compounding earnings, expanding margins, and a premium profit multiple. Curious which assumptions really carry the load? Read on through the full narrative to see how those moving parts connect into a single price tag.
Result: Fair Value of $277.50 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this AMETEK narrative could be challenged if weakness in semiconductor and research end markets lingers, or if acquisition integration fails to deliver expected benefits.
Find out about the key risks to this AMETEK narrative.
Another View on AMETEK’s Valuation
The earlier narrative leans on analyst fair value of $277.50 and concludes AMETEK looks 13.7% undervalued. The Simply Wall St DCF model points in a different direction. On that framework, AMETEK at $239.55 trades above an estimated future cash flow value of $171.70, which screens as overvalued. For investors, the question is which set of assumptions feels more realistic.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out AMETEK for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 48 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With such mixed signals around AMETEK, it helps to look past the headlines and test the numbers yourself. To see what optimism in the data looks like in practice, review the 2 key rewards.
Looking for more investment ideas beyond AMETEK?
If AMETEK has your attention, do not stop there. Use the Simply Wall St Screener to spot other opportunities that match your goals before the market prices them in.
- Target cash rich companies with healthy finances by reviewing the solid balance sheet and fundamentals stocks screener (50 results).
- Hunt for potential value opportunities by scanning through the 48 high quality undervalued stocks.
- Focus on stability and capital protection by starting with the 75 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com